ArticleParasitology research2026
Cystoisospora belli infection in an immunocompetent patient.
Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Cystoisospora belli, also known as Isospora belli, is an opportunistic pathogen which predominantly affects individuals with compromised immunity, including transplant recipients and patients with AIDS, HTLV-1 infections, or hematologic malignancies. The primary symptom of C. belli infection is diarrhea, but the rarity of C. belli infection makes C. belli an uncommon etiology in patients with diarrhea. Only sporadic cases of C. belli infection have been documented in the past century. Diagnosis of C. belli infection in non-endemic regions poses a challenge and delays can escalate mortality risks. This report detailed a unique case of C. belli infection from Guangxi, China involving a male with an intact immune system and no underlying tumor who presented with prolonged diarrhea and bile duct dilatation. C. belli was identified in bile based on acid-fast staining, a rare diagnosis in mainland China and globally. The patient was treated with sulfamethoxazole tablets following diagnosis and responded favorably with significant clinical improvement. This case underscores the importance of considering C. belli in the differential diagnosis of patients with unexplained diarrhea and hepatic ductal dilatation, even though the patient had normal immune function. This finding highlights the need for increased awareness and diagnostic vigilance in both endemic and non-endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.